Skip to main content
SpringerLink
Log in

Effect of neurocatin on the activity of monoamine oxidase B in rat brain synaptosomes

  • Original Articles
  • Published:
Neurochemical Research Aims and scope Submit manuscript

Abstract

Neurocatin, a small (about 2,000 Dalton) neuroregulator isolated from mammalian brain, is a powerful effector of monoamine oxidase B in rat brain synaptosomes. Incubation of intact synaptosomes with neurocatin caused an inhibition of the enzyme dependent on the concentration of neurocatin. This inhibition became statistically significant at a neurocatin concentration of 10 ng/200 μl and was significant at all higher neurocatin concentrations. At 40 ng/200 μl, neurocatin inhibited monoamine oxidase B activity by about 60%. This inhibitory effect was almost completely abolished by breaking the synaptosomal membrane by hypotonic buffer prior to incubation with neurocatin. In addition, incubation of the synaptosomes in calcium free medium almost completely abolished the inhibitory effect of neurocatin on monoamine oxidase B. The inhibition appeared to involve covalent modification of the enzyme mediated by a neurocatin receptor(s). Measurements of the kinetic parameters of the enzyme showed that 20 ng of neurocatin caused a statistically significant decrease in Vmax (by 20%) with no significant change in KM, compared to controls. Inhibition of monoamine oxidase by neurocatin is potentially of great clinical importance because this enzyme plays a major role in catabolism of the biogenic amines and alterations in its activity is believed to contribute to several neurological disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Tipton, K. F. 1986. Enzymology of monoamine oxidase. Cell Biochem. Function 4:79–87.

    Google Scholar 

  2. Fowler, C. J. 1982. Selective inhibitors of monoamine oxidase-A and-B and their clinical usefulness. Drugs Future 7:501–517.

    Google Scholar 

  3. Mantle, T. J. and Tipton, K. F. 1982. Monoamine oxidase A and B: time for reevaluation? Trends Autonom. Pharmacol. 2:523–542.

    Google Scholar 

  4. Weyler, W., Hsu, Y-P., and Breakefield, X. O. 1990. Biochemistry and genetics of monoamine oxidase. Pharmac. Ther. 47:391–417.

    Google Scholar 

  5. Strolin-Benedetti, M., Cini, R., Fusi, R., Marrari, P., and Dostert, P. J. 1990. The effects of aging on MAO activity and amino acid levels in rat brain. Neural. Transm. 29:259–268.

    Google Scholar 

  6. Strolin Benedetti, M. and Keane, P. E. 1980. Differential changes in monoamine oxidase A and B activity in the aging rat brain. J. Neurochem. 35(5):1026–1032.

    Google Scholar 

  7. Adolfsson, R., Gottfries, C.-G., Oreland, L., Wiberg, A., and Winblad, B. 1980. Increased activity of brain and platelet monoamine oxidase activity in dementia of Alzheimer type. Life Sci. 27:1029–1034.

    Google Scholar 

  8. Mann, J. J., Stanley, M., Gerson, S., and Rossor, M. 1980. Mental symptoms in Huntington's disease and a possible primary amineric neuron lesion. Science 210:1369–1371.

    Google Scholar 

  9. Mann, J. J., Kaplan, R. D., and Bird, E. D. 1986. Elevated post mortem monoamine oxidase B activity in the caudate nucleus in Huntington's disease compared to schizophrenics and controls. J. Neural Transm. 65:277–283.

    Google Scholar 

  10. Riederer, P., and Jellinger, K. 1983. Neurochemical insights into MAO inhibitors, with special reference to deprenyl. Acta Neurol. Scand. 95:43–55.

    Google Scholar 

  11. Schneider, G., Oepen, H., and von Wedel, H. R. 1981. MAO aktivitat in verschiedenen Hirngebieten und Korperorganen von Patienten mit Mg Huntington und Mb Parkinson. Arch. Psychiat. Nervenk. 230:5–15.

    Google Scholar 

  12. Willoughby, J., Glover, V., Sandler, M., Albanese, A., Jenner, P., and Marsden, C. D. 1988. Monoamine oxidase activity and distribution in marmoset brain: implications for MPTP toxicity. Neuroscience Letters. 90:100–106.

    Google Scholar 

  13. Chiueh, C. C., Markey, S. P., Burns, R. S., Johannessen, J. N., Jacobwitz, D. M., and Kopin, I. J. 1984. Neurochemical and behavioral effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in rat, guinea pig and monkey. Psychopharmacol. Bull. 20:548–553.

    Google Scholar 

  14. Langston, J. W., Irwin, I., Langston, E. B., and Forno, L. S. 1984. The importance of the 4′–5′ double bound for neurotoxicity in primates of the pyridine derivative MPTP. Neurosci. Lett. 50:289–294.

    Google Scholar 

  15. Markey, S. P., Johannessen, J. N., Chiueh, C. C., Burns, R. S., and Herkenham, M. A. 1984. Intraneuronal generation of a pyridinium metabolite may cause drug induced parkinsonism. Nature 311:464–467.

    Google Scholar 

  16. Strolin Benedetti, M., and Dostert, P. 1987. Overview of the present state of MAO inhibitors. J. Neural. Transm. 23:103–119.

    Google Scholar 

  17. Berrettini, W. H., Vogel, W. H., and Clouse, R. 1977. Platelet monoamine oxidase in chronic schizophrenia. Am. J. Psychiatry 134:805–806.

    Google Scholar 

  18. Murphy, D. L., Belmaker, R., and Wyatt, R. J. 1974. Monoamine oxidase in schizophrenia and other behavioral disorders. J. Psychiatr. Res. 11:221–248.

    Google Scholar 

  19. Murphy, D. L., Donnelly, C. H., Miller, L., and Whyatt, R. J. 1977. Platelet monoamine oxidase in chronic schizophrenia. Arch Gen. Psychiatry 33:1377–1381.

    Google Scholar 

  20. Berrettini, W. H. and Vogel, W. H. 1978. Evidence for an endogenous inhibitor of platelet MAO in chronic schizophrenia. Am. J. Psychiatry 135:605–607.

    Google Scholar 

  21. Becker, R. E. and Giambalvo, C. T. 1982. Endogenous modulation of monoamine oxidase in schizophrenia and normal humans. Am. J. Psychiatry 139:1567–1570.

    Google Scholar 

  22. Ichikawa, K., Hashizume, K., and Yamada, T. 1982. Monoamine oxidase inhibitory modulators in rat heart cytosol: Evidence for induction by thyroid hormone. Endocrinology 111:1803–1809.

    Google Scholar 

  23. Glover, V., Reveley, M. A., and Sandler, M. 1980. A monoamine oxidase inhibitor in human urine. Biochem. Pharmacol 29:467–470.

    Google Scholar 

  24. Glover, V., Bhattacharya, S. K., and Sandler, M. 1981. Benzodiazepines reduce stress-augmented increase in rat urine monoamine oxidase inhibitor. Nature (Lond) 292:347–349.

    Google Scholar 

  25. Egashira, T., Takano, R., and Yamanaka, Y. 1986. Demonstration of endogenous inhibitors of monoamine oxidase in dog cerebrospinal fluid. Japan J. Pharmacol 42:583–586.

    Google Scholar 

  26. Becker, R. E., Giamvalvo, C. T., Fox, R. A., and Macho, M. 1983. Endogenous inhibitors of monoamine oxidase present in human cerebrospinal fluid. Science 221:476–478.

    Google Scholar 

  27. Fernandez-Novoa, L., Pastuszko, A., and Wilson, D. F. 1991. Neurocatin induced inhibition of monoamine oxidase A in rat brain synaptosomes. Biochem. Pharm. 42:2351–2354.

    Google Scholar 

  28. Yee, D. K., Pastuszko, P., Pastuszko, A., and Wilson, D. F. 1990. Purification of neurocatin, a neuroregulatory factor from brain. Neurosci. Letters 114:213–219.

    Google Scholar 

  29. Booth, R. F. G. and Clark, J. B. 1978. A rapid method for the preparation of relatively pure metabolically competent synaptosomes from rat brain. Biochem. J. 176:365–370.

    Google Scholar 

  30. Wurtman, R. J. and Alexrod, J. 1963. A sensitive and specific assay for the estimation of monoamine oxidase. Biochem. Pharmacol 12:1439–1441.

    Google Scholar 

  31. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. 1951. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:265–275.

    Google Scholar 

  32. Tipton, K. F. 1968. The prosthetic grups of pig brain mitochondrial monoamine oxidase. Biochim. Biophys. Acta 159:451–459.

    Google Scholar 

  33. Ambani, L. M., Van Woert, M. H., and Murphy, S. 1975. Brain peroxidase and catalase in Parkinson Disease. Arch Neurol. 32:114–118.

    Google Scholar 

  34. Cohen, G., Dembiec, D., Mytilineou, C., and Heikkila, R. E. 1976. Oxygen radicals and the integrity of the nigrostriatal tract, in Adv. in Parkinsonism. Biochemistry, Physiology, Treatment Pages 251–257.in (Birkmayer, W., and Hornykiewicz, (eds) Editiones Roche, Basle.

    Google Scholar 

  35. Cohen, G. and Heikkila, R. E. 1978. Mechanisms of action of hydroxylated phenylethylamine and indoleamine neurotoxins. Ann. N. Y. Acad. Sci. 305:74–84.

    Google Scholar 

  36. Matsui, Y., and Kumagae, Y. 1991. Monoamine oxidase inhibitors prevent striatal neuronal necrosis induced by transient forebrain ischemia. Neuroscience Lett. 126:175–178.

    Google Scholar 

  37. Giambalvo, C. T., and Becker, R. E. 1981. Modulators of monoamine oxidase in plasma. Life Sci. 29:2017–2024.

    Google Scholar 

  38. Egashira, T., Obata, T., Nagai, T., Kimba, Y., Takano, R., and Yamanaka, Y. 1989. Endogenous monoamine oxidase inhibitorlike substances in moneky brain. Biochem. Pharmacol. 38:597–602.

    Google Scholar 

  39. Yu, P. H., and Boulton, A. A. 1979. Activation of platelet monoamine oxidase by plasma in the humans. Life Sci. 25:31–36.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biochemistry and Biophysics, Medical School, University of Pennsylvania, 19104, Philadelphia, Pennsylvania

    Stephanie Murphy & Anna Pastuszko

Authors
  1. Stephanie Murphy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anna Pastuszko
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Murphy, S., Pastuszko, A. Effect of neurocatin on the activity of monoamine oxidase B in rat brain synaptosomes. Neurochem Res 19, 177–182 (1994). https://doi.org/10.1007/BF00966813

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00966813

Key Words

Search

Navigation